Polymarket Seeks Investment at Valuation of $12B-$15B: Bloomberg
Thursday, October 23rd 2025, 9:51:40 am
website
Rival Kalshi is now in talks for further investment that would value it after over $10 billion, having recently raised $300 million at a $5 billion valuation
Breaking
Kenvue, the maker of Tylenol, last week submitted a 42-page response to the FDA, stating that scientific evidence does not support claims of a connection between acetaminophen and autism. Doctors, law...
